Science that gotto market.

Context — A genomics platform had cleared regulatory review with no commercial motion behind it — strong science, no route to clinical and research buyers across three regions.

What we did — Positioning and claims built with the science team, a launch narrative that stayed FDA- and EMA-safe, and a full campaign and enablement package shipped region by region.

Outcome — 0 to 200 B2B customers in two years across three regions.

Context — A Series A team had outgrown its original story: the product had moved on, the market framing hadn't, and the company narrative had to hold up in far more serious rooms.

What we did — Repositioned the company, rebuilt the narrative and the press motion around it, and ran the customer communication through a period of intense change.

Outcome — Repositioning and PR ahead of an acquisition, with 95% client retention held throughout.

Context — Climate data with real buyers behind it, but field marketing ran on instinct — no tracking, no attribution, and no view of which markets were worth expanding into.

What we did — Rebuilt field marketing into a tracked pipeline engine: instrumented the funnel, tightened the proof-led narrative, and staged entry into new country markets.

Outcome — +25% YoY pipeline growth and five new country markets opened.